Stock BEAT HEARTBEAM, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News HeartBeam, Inc.

Equities

BEAT

US42238H1086

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-14 EDT 		5-day change 1st Jan Change
2.06 USD +3.00% Intraday chart for HeartBeam, Inc. +0.49% -12.34%
05-09 Transcript : HeartBeam, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09 HeartBeam, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HeartBeam AIMIGo Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
AQ
HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
BU
Transcript : HeartBeam, Inc., Q1 2024 Earnings Call, May 09, 2024
HeartBeam Reports First Quarter 2024 Results
BU
HeartBeam, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
BU
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
BU
HeartBeam, Inc. Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
CI
Transcript : HeartBeam, Inc., Q4 2023 Earnings Call, Mar 20, 2024
HeartBeam : Fourth Quarter 2023 Earnings Conference Call Presentation
PU
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
BU
First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo System for synthesizing a 12-Lead ECG
AQ
First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG
BU
HeartBeam, Inc. Announces First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo System for Synthesizing A 12-Lead ECG
CI
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology
BU
HeartBeam, Inc. Receives Two New US Patents for Its Core Cardiac Monitoring Technology
CI
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time
BU
HeartBeam, Inc. Announces Retirement of Richard Brounstein as Chief Financial Officer
CI
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BEAT Stock
  4. News HeartBeam, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW